Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems

The purpose of this study is to compare the rate of successful urodynamics procedure completion between a prospective intervention group and a historical control group after a pre-procedure patient reminder system to determine whether the intervention improves procedural success and healthcare delivery. The impact of the reminder system on patient satisfaction, preparedness, and anxiety will also be evaluated.

Study Overview

• Status: Not yet recruiting
• Conditions: Urinary Incontinence; Pelvic Organ Prolapse
• Intervention / Treatment: Other: Patient reminder system

• Study Type: Interventional
• Enrollment (Estimated): 162
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Lisa Hickman, MD; Phone Number: 614-814-8205; Email: Lisa.Hickman@osumc.edu
• Study Contact Backup: Name: Ashka Shah; Email: Ashka.Shah@osumc.edu

Study Locations

• United States
  • Ohio
    • Columbus, Ohio, United States, 43210
      • Ohio State University Wexner Medical Center
      • Contact: Lisa Hickman, MD; Phone Number: 614-814-8205; Email: Lisa.Hickman@osumc.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria

1. Age 18 years or older
2. Sex assigned at birth: Female.
3. English-speaking
4. Scheduled to undergo a urodynamics study at the OSU Upper Arlington Outpatient Clinic, OSU New Albany Outpatient Clinic, or OSU Eye and Ear Institute
5. Ability to access a telephone
6. Active MyChart account
7. Ability to provide informed consent
8. Documented post-residual volume of 150 mL
9. Ability to be reached by telephone after three call attempts
10. Negative point-of-care urinary tract infection on the day of the scheduled procedure (SOC)

Exclusion criteria:

1. Under 18 years of age
2. Patients with structural causes of urinary retention/incomplete bladder emptying (defined as a post-void residual >150ml) or a positive point-of-care urinary tract infection on the day of the procedure.
3. Men are excluded as the population of interest is the female urogynecology population in both urology and obstetrics and gynecology.
4. Patients without access to a telephone or an active MyChart account are excluded because the intervention relies on telephone calls and electronic messaging for delivery of pre-procedure education and reminders.
5. Individuals who cannot be reached by telephone are excluded because they cannot receive the intervention.
6. Non-English speaking individuals are excluded because they will not be able to receive the standardized phone call in English and will not be able to complete the informed consent.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: using patient reminder systems before scheduled urodynamics studies; The study intervention will include all participating patients receiving a phone call from a study team member reading from a script before their scheduled appointment. The phone call will involve consenting the patient for the study and a reminder to come in for the study with a comfortably full bladder, avoiding utilizing the lobby restroom before the appointment.	Other: Patient reminder system; Using patient reminder systems before scheduled urodynamics studies on patient satisfaction, preparedness, anxiety, and successful completion of the procedure to improve healthcare delivery by comparing a prospective intervention group with a historical control group.
No Intervention: not using patient reminder systems before scheduled urodynamics studies; Participants for the historical control group will be identified through retrospective review of electronic medical records of patients who previously underwent scheduled urodynamics studies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percent decrease in urodynamics procedure completion failure rate in patients who received the reminder system before scheduled urodynamics procedures vs. patients who did not receive the reminder	Completion failure is defined as a uroflow less than 150 mL	From enrollment to the end of the urodynamics study (less than 1 week)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evaluate anxiety before and after a urodynamics (UDS) procedure after delivery of a patient reminder system.	Anxiety is measured by patient completion of ST-STAI before and after the UDS study.	From enrollment to the end of the urodynamics study (less than 1 week)
Evaluate patient satisfaction and preparedness before and after a urodynamic study after delivery of a patient reminder system.	Patient satisfaction and preparedness for the procedure will be assessed using Likert-style items via a survey issued to patients before and after the UDS study.	From enrollment to the end of the urodynamics study (less than 1 week)

Collaborators and Investigators

• Sponsor: Ohio State University

Study record dates

Study Major Dates

• Study Start (Estimated): July 1, 2026
• Primary Completion (Estimated): June 1, 2027
• Study Completion (Estimated): December 1, 2027

Study Registration Dates

• First Submitted: July 2, 2026
• First Submitted That Met QC Criteria: July 2, 2026
• First Posted (Actual): July 9, 2026

Study Record Updates

• Last Update Posted (Actual): July 9, 2026
• Last Update Submitted That Met QC Criteria: July 2, 2026
• Last Verified: July 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urogenital Diseases; Male Urogenital Diseases; Pathological Conditions, Anatomical; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urination Disorders; Lower Urinary Tract Symptoms; Urological Manifestations; Prolapse; Pathological Conditions, Signs and Symptoms; Signs and Symptoms; Urinary Incontinence; Pelvic Organ Prolapse
• Other Study ID Numbers: STUDY20260760

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No